Gly-low

1. Gly-low inhibits cellular senescence in human cells.

   “Chronic MGO exposure elevated biomarkers of cellular senescence in HAECs, comparable to a known senescence inducer Doxorubicin, an effect partially blocked by Gly-Low.”

   CellsMGO-exposed

   Methylglyoxal-induced glycation stress promotes aortic stiffening: putative mechanistic roles of oxidative stress and cellular senescence

   Aging·14 Nov 2025

More on Cellular senescence

1. Gly-low decreases aortic elastic modulus in mice (mitigated ~100% increase).

   “Ex vivo, MGO increased aortic elastic modulus ~100% (P<0.05), superoxide production by ~40% (P<0.05), and MGH-1 expression by 50% (P<0.05), which were all mitigated by Gly-Low.”

   Animalsex vivo aorta

   Methylglyoxal-induced glycation stress promotes aortic stiffening: putative mechanistic roles of oxidative stress and cellular senescence

   Aging·14 Nov 2025

1. Gly-low decreases pulse wave velocity in mice (prevented 21% increase).

   “MGO-induced glycation stress increased PWV in young mice by 21% (P<0.05 vs. control), which was prevented with Gly-Low (P=0.93 vs. control).”

   AnimalsMGO-supplementedin chowaorta

   Methylglyoxal-induced glycation stress promotes aortic stiffening: putative mechanistic roles of oxidative stress and cellular senescence

   Aging·14 Nov 2025

More on Pulse wave velocity